HOME >> MEDICINE >> NEWS
Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find

(PHILADELPHIA) Common blood pressure medications might help block the spread of pancreatic cancer, researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found. The scientists showed in laboratory studies that two types of pressure-lowering drugs ACE inhibitors and AT1R blockers may help reduce the development of tumor-feeding blood vessels, a process called angiogenesis. Such drugs, they say, may become part of a novel strategy to control the growth and spread of cancer.

According to Hwyda Arafat, M.D., Ph.D., assistant professor of surgery at Jefferson Medical College, previous studies have linked a lower cancer incidence with the inhibition of the pancreas hormone angiotensin II (Ang II) by either ACE (Angiotensin I converting enzyme) inhibitors or AT1R (Ang II type 1 receptor) blockers. Ang II increases the production of VEGF, a vascular factor that promotes blood vessel growth in a number of cancers. High VEGF levels have been correlated with poor cancer prognosis and early recurrence. ACE is the enzyme that converts Ang I to Ang II.

Dr. Arafat and her co-workers examined the protein of both invasive pancreatic cancer and normal pancreatic tissue, analyzing the expression of ACE and AT1R in relation to VEGF. They also looked at the effects of blood pressure drugs captopril, an ACE inhibitor, and losartan, an AT1R blocker, on VEGF production in cancer cell lines.

They found that protein levels in ACE and AT1R were significantly higher in 75 percent of the cancer tissue examined. VEGF expression was higher in cases where there was strong ACE and AT1R levels. In the test tube, Ang II significantly enhanced VEGF production in AT1R-positive cells. Captopril and losartan both blocked this effect.

"Our data show for the first time that both ACE and AT1R are functionally expressed in pancreatic ductal adenocarcinoma and suggest their involvement in tumor angiogenesis," Dr. Arafat says. She
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
7-Dec-2006


Page: 1 2

Related medicine news :

1. Blood inflammation plays role in Alzheimers disease
2. Blood-thinning drugs need closer monitoring
3. Blood transfusions from precancerous blood donors do not increase risk of cancer
4. Blood marker helps predict prognosis among those with abdominal infection
5. Blood transfusions raise heart patients infection and death risk -- especially women
6. Blood cells linked to heart attacks, other inflammatory diseases
7. Blood transfusion-transmitted infections: A global perspective
8. Blood clots can be treated by injections at home
9. Blood pressure variability increases risk for stroke death
10. Blood pressure drugs associated with reduced risk of esophageal, pancreatic and colon cancers
11. Canadian Blood Services scientist invents potential alternative for high-demand blood product

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2019)... ... November 15, 2019 , ... ... webinar on comprehensive school physical activity programs (CSPAP) on December 3, 2019 at ... recreation and park professionals, this one-hour and 15-minute webinar will discuss the five ...
(Date:11/14/2019)... ... , ... With Giving Tuesday on Dec. 3, 2019, the ... about the benefits of supporting local hospitalized veterans throughout Maryland. Created in 2012, ... to give, collaborate and celebrate generosity before the holidays, and enables participants to ...
(Date:11/14/2019)... ... November 14, 2019 , ... BioInformatics Inc., part of Science and ... today announced that 7 companies have been nominated for a Life Science Industry ... Since 2002, the Life Science Industry Awards have recognized manufacturers of the “tools of ...
(Date:11/12/2019)... Ind. (PRWEB) , ... November 12, 2019 , ... ... a select group of individuals/organizations who have truly impacted those diagnosed with infertility. ... received RESOLVE’s prestigious Hope Award for Achievement, presented at the Night of Hope ...
(Date:11/12/2019)... ... 2019 , ... The quality of study start-up can dictate ... contract negotiations and 80 percent of organizations still using spreadsheets to track activities, ... improvement. Following an overview of the challenges facing trial sponsors, this webinar will ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... November 11, 2019 , ... PRP Science , Florida’s ... is now representing two of the most respected manufacturers in the medical aesthetics arena; ... Ameia Med is the leading developer of the EXCEED micro-needling device ...
(Date:11/11/2019)... ... November 11, 2019 , ... Attorneys representing an ... statement before U.S. Bankruptcy Court Judge Robert Drain in White Plains, NY notifying ... prescription opioid epidemic cannot be forgotten as a $12 billion settlement is considered. ...
(Date:11/11/2019)... ... November 11, 2019 , ... Over 60 schools in the northwest panhandle of ... program is designed to provide virtual mental health care to more than 35,000 students ... in October of 2018 [1]. , “This initiative by the state of Florida,” says ...
Breaking Medicine Technology:
Cached News: